[Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus].
The authors presented the results of a study of human insulin drugs Monotard HM and Actrapid HM (Novo, Denmark) for type I diabetes mellitus. They stressed their efficacy in therapy of insulin dependent diabetes mellitus: a course of disease became less labile, the time of achieving compensation was reduced; the drugs proved to be effective in the treatment of post-injection insulinlipodystrophies, in body mass deficiency; a tendency to a decrease in daily insulin requirement, serum insulin binding capacity, and in increase in the content of free insulin were noted.
Perelygina
A A
AA
Smirnova
O M
OM
Lobanova
A M
AM
Gorelysheva
V A
VA
D000293:Adolescent; D000328:Adult; D003692:Delayed-Action Preparations; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood / Q000627:therapeutic use*; D007330:Insulin Antibodies / Q000032:analysis; D008297:Male; D008875:Middle Aged
D003692:Delayed-Action Preparations; D007328:Insulin; D007330:Insulin Antibodies
Primenenie preparatov chelovecheskogo insulina pri lechenii bol'nykh insulinzavisimym sakharnym diabetom.